Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Silverman

Showing results (741-750 of 756) with videos related to

Pageof 76
Sort By:
Journal of the American Academy of Dermatology|May 13, 2014
Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapiesLawrence F Eichenfield, Wynnis L Tom, Timothy G Berger, et al.
Journal of the American Academy of Dermatology|December 3, 2013
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitisLawrence F Eichenfield, Wynnis L Tom, Sarah L Chamlin, et al.
Human Molecular Genetics|December 30, 2025
Phenotypic expansion of CALM1/2-associated disorders to include neurologic phenotypes without arrhythmiaHieu D Hoang, Rebecca C Spillmann, Daniel J Wegner, et al.
Science Translational Medicine|September 10, 2020
Therapeutic responses to <i>Roseomonas mucosa</i> in atopic dermatitis may involve lipid-mediated TNF-related epithelial repairIan A Myles, Carlo R Castillo, Kent D Barbian, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
Discovery of a potent and selective aurora kinase inhibitorJohan D Oslob, Michael J Romanowski, Darin A Allen, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicitySimone Punt, Shruti Malu, Jodi A McKenzie, et al.
Nature|November 17, 2022
Enterococci enhance Clostridioides difficile pathogenesisAlexander B Smith, Matthew L Jenior, Orlaith Keenan, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
2-Aminobenzimidazoles as potent Aurora kinase inhibitorsMin Zhong, Minna Bui, Wang Shen, et al.
Plos Genetics|November 7, 2023
Dominant negative variants in KIF5B cause osteogenesis imperfecta via down regulation of mTOR signalingRonit Marom, Bo Zhang, Megan E Washington, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Dominant negative ATP5F1A variants disrupt oxidative phosphorylation causing neurological disordersSara M Fielder, Marisa W Friederich, Daniella H Hock, et al.
Pageof 76

Showing results (741-750 of 756) with videos related to

Sort By:
Pageof 76
Journal of the American Academy of Dermatology|May 13, 2014
Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapiesLawrence F Eichenfield, Wynnis L Tom, Timothy G Berger, et al.
Journal of the American Academy of Dermatology|December 3, 2013
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitisLawrence F Eichenfield, Wynnis L Tom, Sarah L Chamlin, et al.
Human Molecular Genetics|December 30, 2025
Phenotypic expansion of CALM1/2-associated disorders to include neurologic phenotypes without arrhythmiaHieu D Hoang, Rebecca C Spillmann, Daniel J Wegner, et al.
Science Translational Medicine|September 10, 2020
Therapeutic responses to <i>Roseomonas mucosa</i> in atopic dermatitis may involve lipid-mediated TNF-related epithelial repairIan A Myles, Carlo R Castillo, Kent D Barbian, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
Discovery of a potent and selective aurora kinase inhibitorJohan D Oslob, Michael J Romanowski, Darin A Allen, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicitySimone Punt, Shruti Malu, Jodi A McKenzie, et al.
Nature|November 17, 2022
Enterococci enhance Clostridioides difficile pathogenesisAlexander B Smith, Matthew L Jenior, Orlaith Keenan, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
2-Aminobenzimidazoles as potent Aurora kinase inhibitorsMin Zhong, Minna Bui, Wang Shen, et al.
Plos Genetics|November 7, 2023
Dominant negative variants in KIF5B cause osteogenesis imperfecta via down regulation of mTOR signalingRonit Marom, Bo Zhang, Megan E Washington, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Dominant negative ATP5F1A variants disrupt oxidative phosphorylation causing neurological disordersSara M Fielder, Marisa W Friederich, Daniella H Hock, et al.
Pageof 76